ADPRYVDA
Live / Applied — Fourth extension granted (statement of use) (as of 11 Dec 2025)
What this means for you
Not registered yet, but its 30 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97484320
- Mark type
- Stylized text
- Filed
- 30 Jun 2022
- Published for opposition
- 31 Oct 2023
- Attorney of record
- Joe McKinney Muncy
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of metabolic disorders
Owner
- Polaris Pharmaceuticals, Inc., San Diego, CA, US
- Polaris Pharmaceuticals, Inc., San Diego, CA, US
Prosecution history
- 12 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Dec 2025 — SOU EXTENSION 4 GRANTED
- 11 Dec 2025 — SOU EXTENSION 4 FILED
- 11 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Aug 2025 — SOU EXTENSION 3 GRANTED
- 25 Jun 2025 — SOU EXTENSION 3 FILED
- 24 Jul 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 24 Jul 2025 — NOTICE OF REVIVAL - E-MAILED
- 24 Jul 2025 — PETITION TO REVIVE-GRANTED
- 24 Jul 2025 — TEAS PETITION TO REVIVE RECEIVED
- 11 Dec 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 Dec 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 11 Dec 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED